Accelerate to discover
Related topics
Webinar recording: 4D monitoring of bone and (re)modeling events using in vivo micro-CT
Dec 4, 2019
Micro-CT is a powerful tool for the longitudinal monitoring of bones to acquire bone mass and architectural changes in...
Bioflux webinar: Flow dynamics influence on biofilm formation by Proteus mirabilis
Dec 2, 2019
Catheter blockage by ureolytic biofilm-forming pathogens is a significant problem for health services, with 2,000...
Nov 27, 2019
Learn about new SpectroFlo version 2.2.0. Innovative software tools from Cytek Biosciences and De Novo Software that...
Nov 14, 2019
Today watch this interesting video interview with Anabela Bensimon-Brito, Department of Developmental Genetics, Max...
Preclinical hyperpolarized carbon-13 magnetic resonance imaging in neurological disease models
Nov 8, 2019
Hyperpolarized (HP)-13C MR is proven as a viable tool for imaging of neurological disorders often associated with...
Imaging Flow Cytometry webinar: aging cells, giant viruses using AMNIS platform
Nov 6, 2019
In this webinar we will describe three recent applications for imaging flow cytometry (IFC), a technology that combines...
Webinar recording: Use of ultra-high field MRI for in and ex vivo neuroimaging
Nov 6, 2019
The relatively low T1 contrast, long T1 values at higher fields lead to the necessity to adapt sequences commonly used...
Webinar recording: Analysis of extracellular vesicles by AMNIS imaging flow cytometer
Nov 4, 2019
Although conventional flow cytometry is limited to measure small particles down to approximately 300 nm – 500 nm, an...
Nov 22, 2018
Researchers developed an assay to measure CLL cell interactions with endothelium under shear force using a Bioflux 200 and blocked CD62L using the anti-CD62L antibody DREG-56. CLL cell interactions with endothelium were visualized by time-lapse microscopy and CLL cell movement was tracked and quantified. Data will be discussed in the webinar and will establish targeting CD62L inhibits CLL cell/endothelial cell interactions and is accentuated by co-administration with ibrutinib. These data imply that some of the clinical effects caused by ibrutinib are due to a reduced capacity of CLL cells to engage endothelium and extravasate.
Dr. Chris Pepper, Professor in Cancer Studies, University of Sussex, UK
Related technologies: Cell interaction studies
Get more info
Brand profile
With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.
More info at:
www.fluxionbio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
